Commons Capital - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Mười câu hỏi và mười câu trả lời để làm rõ “hộp đen” của nhà tạo lập thị trường: Tại sao các nhà đầu tư mạo hiểm lại tham gia vào hoạt động tạo lập thị trường? Liệu chủ dự án có thực sự dễ bị đâm sau lưng không?

Bitcoin $84,541.61 +1.63%
Ethereum $1,942.85 +3.29%
BNB $628.94 +5.04%
Optimism $0.91 +10.06%
Arbitrum $0.37 +6.83%
Solana $130.12 +2.71%
Polygon $0.22 +4.19%
Cosmos $4.64 +0.78%
Avalanche $18.98 +3.43%

Bitcoin $84,541.61 +1.63%
Ethereum $1,942.85 +3.29%
BNB $628.94 +5.04%
Optimism $0.91 +10.06%
Arbitrum $0.37 +6.83%
Solana $130.12 +2.71%
Polygon $0.22 +4.19%
Cosmos $4.64 +0.78%
Avalanche $18.98 +3.43%

Commons Capital

investment firm

Summary
Investments
Exits
Employees

About

Commons Capital is an early-stage venture capital fund focused on clean energy, environment, education, and healthcare sectors.

Brookline,Massachusetts,United States
http://www.commonscapital.com

Highlights

Lead Investments

Employee Profiles

Details

Operating Status: Active
Investor Type: Venture Capital

Investments

Number of Investments

Number of Lead Investments

13

1

Commons Capital has made 13 investments. Their most recent investment was on May 27, 2011, when HistoRx raised $2.60M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
May 27, 2011 HistoRx	Series Unknown	$2.60M	Alternative Medicine	—
Dec 17, 2009 Combinent Biomedical Systems	Series Unknown	$500K	Biotechnology	—
Mar 23, 2009 Claros Diagnostics	Series B	$4M	Genetics	—
Nov 14, 2008 CodeRyte	Series D	$13M	Health Care	—
Oct 24, 2007 HistoRx	Series B	$6M	Alternative Medicine	—

Show More

Employee Profiles

Number of Employee Profiles

1

Commons Capital has 1 current employee profiles, including Executive William Osborn

Executive

Exits

Commons Capital has had 5 exits. Commons Capital most notable exits include Protonex Technology Corporation , HistoRx

Date	Company Name	Exit Type	Industry
Jun 29, 2015	Protonex Technology Corporation	M&A	Electronics	Detail
Sep 1, 2012	HistoRx	M&A	Alternative Medicine	Detail
Apr 10, 2012	CodeRyte	M&A	Health Care	Detail
Oct 13, 2011	Claros Diagnostics	M&A	Genetics	Detail
Dec 1, 2009	H2Gen Innovations	M&A	Manufacturing	Detail